Analysts’ Recent Ratings Changes for McKesson (MCK)

Several analysts have recently updated their ratings and price targets for McKesson (NYSE: MCK):

• 11/13/2024 – McKesson had its price target raised by analysts at Citigroup Inc. from $630.00 to $713.00. They now have a “buy” rating on the stock.
• 11/7/2024 – McKesson was upgraded by analysts at Baird R W from a “hold” rating to a “strong-buy” rating.
• 11/7/2024 – McKesson had its price target raised by analysts at Evercore ISI from $560.00 to $680.00. They now have an “outperform” rating on the stock.
• 11/7/2024 – McKesson was upgraded by analysts at Robert W. Baird from a “neutral” rating to an “outperform” rating. They now have a $688.00 price target on the stock, up previously from $531.00.
• 11/6/2024 – McKesson was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating.
• 10/7/2024 – McKesson had its price target lowered by analysts at Leerink Partners from $665.00 to $630.00. They now have an “outperform” rating on the stock.
• 9/27/2024 – McKesson was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating.
• 9/25/2024 – McKesson had its price target lowered by analysts at Deutsche Bank Aktiengesellschaft from $623.00 to $579.00. They now have a “buy” rating on the stock.
• 9/24/2024 – McKesson had its “neutral” rating reaffirmed by analysts at Robert W. Baird. They now have a $531.00 price target on the stock, down previously from $603.00.
• 9/24/2024 – McKesson was downgraded by analysts at Baird R W from a “strong-buy” rating to a “hold” rating.

McKesson Stock Performance

McKesson stock traded up $6.95 during midday trading on Wednesday, reaching $624.61. 636,008 shares of the stock were exchanged, compared to its average volume of 824,294. The firm has a market cap of $79.29 billion, a PE ratio of 32.35, a PEG ratio of 1.33 and a beta of 0.44. McKesson Co. has a 52 week low of $431.35 and a 52 week high of $637.51. The company’s fifty day moving average is $515.00 and its 200-day moving average is $552.91.

McKesson (NYSE:MCK) last released its earnings results on Wednesday, November 6th. The company reported $7.07 EPS for the quarter, beating analysts’ consensus estimates of $6.88 by $0.19. McKesson had a negative return on equity of 207.50% and a net margin of 0.77%. The business had revenue of $93.65 billion for the quarter, compared to analysts’ expectations of $89.33 billion. During the same quarter in the prior year, the firm earned $6.23 earnings per share. The firm’s revenue was up 21.3% on a year-over-year basis. On average, sell-side analysts anticipate that McKesson Co. will post 32.81 earnings per share for the current fiscal year.

McKesson Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, January 2nd. Shareholders of record on Monday, December 2nd will be given a $0.71 dividend. The ex-dividend date of this dividend is Monday, December 2nd. This represents a $2.84 annualized dividend and a yield of 0.45%. McKesson’s payout ratio is currently 14.71%.

Insider Activity at McKesson

In other news, CEO Brian S. Tyler sold 3,753 shares of the business’s stock in a transaction that occurred on Thursday, September 5th. The stock was sold at an average price of $561.10, for a total transaction of $2,105,808.30. Following the transaction, the chief executive officer now directly owns 78,586 shares of the company’s stock, valued at approximately $44,094,604.60. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.11% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On McKesson

Several hedge funds and other institutional investors have recently modified their holdings of MCK. LRI Investments LLC bought a new stake in McKesson during the 1st quarter valued at about $28,000. Wolff Wiese Magana LLC grew its position in shares of McKesson by 742.9% during the 3rd quarter. Wolff Wiese Magana LLC now owns 59 shares of the company’s stock valued at $29,000 after acquiring an additional 52 shares during the period. MidAtlantic Capital Management Inc. purchased a new stake in McKesson in the third quarter worth about $29,000. ORG Wealth Partners LLC bought a new stake in McKesson during the 3rd quarter worth approximately $40,000. Finally, Carmichael Hill & Associates Inc. purchased a new position in shares of McKesson during the 2nd quarter valued at $52,000. Hedge funds and other institutional investors own 85.07% of the company’s stock.

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.